Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARREST: Aramchol in NASH
NCT02279524Phase 2Completed
- Sponsor
- Galmed Pharmaceuticals
- Start
- Apr 2015
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of aramchol in Nonalcoholic steatohepatitis (NASH), sponsored by Galmed Pharmaceuticals. Started Apr 2015; status: completed.
02
Drugs
aramchol
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT02279524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02279524.